Encyclopedia > TNX-901

  Article Content

TNX-901

TNX-901 is a drug being tested at National Jewish Medical and Research Center and other locations across America. It is believed that the drug may prevent reactions to small amounts of peanuts, such as reminant in foods.

The U.S. Food and Drug Administration[?] (FDA) has "fast-tracked" the drug. A drug is given fast-track status if it meets a medical need not currently being met by any medication.

It is made by a Houston-based company called Tanox[?]; there is a legal dispute against this lab that the drug is based on the same anti-asthma sciences paid for by Genentech and Novartis.

External Link



All Wikipedia text is available under the terms of the GNU Free Documentation License

 
  Search Encyclopedia

Search over one million articles, find something about almost anything!
 
 
  
  Featured Article
Kings Park, New York

... the population is spread out with 25.2% under the age of 18, 5.7% from 18 to 24, 31.9% from 25 to 44, 23.3% from 45 to 64, and 13.9% who are 65 years of age or older. ...

 
 
 
This page was created in 23 ms